Cargando…
PB1938: REAL WORLD EFFECTIVENESS AND SAFETY OF VENETOCLAX IN COMBINATION WITH OBINUTUZUMAB IN TREATMENT NAIVE CLL PATIENTS – DATA FROM THE OBSERVATIONAL STUDY VERVE
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429845/ http://dx.doi.org/10.1097/01.HS9.0000974572.50349.42 |
| _version_ | 1785090813295853568 |
|---|---|
| author | Schwaner, Ingo Hebart, Holger Christoph, Losem Thomas, Wolff Burkard, Schmidt Rossi, Davide Caroline, Lehmann Julia, Benzel Johannes, Huelsenbeck Petra, Pichler |
| author_facet | Schwaner, Ingo Hebart, Holger Christoph, Losem Thomas, Wolff Burkard, Schmidt Rossi, Davide Caroline, Lehmann Julia, Benzel Johannes, Huelsenbeck Petra, Pichler |
| author_sort | Schwaner, Ingo |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10429845 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104298452023-08-17 PB1938: REAL WORLD EFFECTIVENESS AND SAFETY OF VENETOCLAX IN COMBINATION WITH OBINUTUZUMAB IN TREATMENT NAIVE CLL PATIENTS – DATA FROM THE OBSERVATIONAL STUDY VERVE Schwaner, Ingo Hebart, Holger Christoph, Losem Thomas, Wolff Burkard, Schmidt Rossi, Davide Caroline, Lehmann Julia, Benzel Johannes, Huelsenbeck Petra, Pichler Hemasphere Publication Only Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10429845/ http://dx.doi.org/10.1097/01.HS9.0000974572.50349.42 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Publication Only Schwaner, Ingo Hebart, Holger Christoph, Losem Thomas, Wolff Burkard, Schmidt Rossi, Davide Caroline, Lehmann Julia, Benzel Johannes, Huelsenbeck Petra, Pichler PB1938: REAL WORLD EFFECTIVENESS AND SAFETY OF VENETOCLAX IN COMBINATION WITH OBINUTUZUMAB IN TREATMENT NAIVE CLL PATIENTS – DATA FROM THE OBSERVATIONAL STUDY VERVE |
| title | PB1938: REAL WORLD EFFECTIVENESS AND SAFETY OF VENETOCLAX IN COMBINATION WITH OBINUTUZUMAB IN TREATMENT NAIVE CLL PATIENTS – DATA FROM THE OBSERVATIONAL STUDY VERVE |
| title_full | PB1938: REAL WORLD EFFECTIVENESS AND SAFETY OF VENETOCLAX IN COMBINATION WITH OBINUTUZUMAB IN TREATMENT NAIVE CLL PATIENTS – DATA FROM THE OBSERVATIONAL STUDY VERVE |
| title_fullStr | PB1938: REAL WORLD EFFECTIVENESS AND SAFETY OF VENETOCLAX IN COMBINATION WITH OBINUTUZUMAB IN TREATMENT NAIVE CLL PATIENTS – DATA FROM THE OBSERVATIONAL STUDY VERVE |
| title_full_unstemmed | PB1938: REAL WORLD EFFECTIVENESS AND SAFETY OF VENETOCLAX IN COMBINATION WITH OBINUTUZUMAB IN TREATMENT NAIVE CLL PATIENTS – DATA FROM THE OBSERVATIONAL STUDY VERVE |
| title_short | PB1938: REAL WORLD EFFECTIVENESS AND SAFETY OF VENETOCLAX IN COMBINATION WITH OBINUTUZUMAB IN TREATMENT NAIVE CLL PATIENTS – DATA FROM THE OBSERVATIONAL STUDY VERVE |
| title_sort | pb1938: real world effectiveness and safety of venetoclax in combination with obinutuzumab in treatment naive cll patients – data from the observational study verve |
| topic | Publication Only |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429845/ http://dx.doi.org/10.1097/01.HS9.0000974572.50349.42 |
| work_keys_str_mv | AT schwaneringo pb1938realworldeffectivenessandsafetyofvenetoclaxincombinationwithobinutuzumabintreatmentnaivecllpatientsdatafromtheobservationalstudyverve AT hebartholger pb1938realworldeffectivenessandsafetyofvenetoclaxincombinationwithobinutuzumabintreatmentnaivecllpatientsdatafromtheobservationalstudyverve AT christophlosem pb1938realworldeffectivenessandsafetyofvenetoclaxincombinationwithobinutuzumabintreatmentnaivecllpatientsdatafromtheobservationalstudyverve AT thomaswolff pb1938realworldeffectivenessandsafetyofvenetoclaxincombinationwithobinutuzumabintreatmentnaivecllpatientsdatafromtheobservationalstudyverve AT burkardschmidt pb1938realworldeffectivenessandsafetyofvenetoclaxincombinationwithobinutuzumabintreatmentnaivecllpatientsdatafromtheobservationalstudyverve AT rossidavide pb1938realworldeffectivenessandsafetyofvenetoclaxincombinationwithobinutuzumabintreatmentnaivecllpatientsdatafromtheobservationalstudyverve AT carolinelehmann pb1938realworldeffectivenessandsafetyofvenetoclaxincombinationwithobinutuzumabintreatmentnaivecllpatientsdatafromtheobservationalstudyverve AT juliabenzel pb1938realworldeffectivenessandsafetyofvenetoclaxincombinationwithobinutuzumabintreatmentnaivecllpatientsdatafromtheobservationalstudyverve AT johanneshuelsenbeck pb1938realworldeffectivenessandsafetyofvenetoclaxincombinationwithobinutuzumabintreatmentnaivecllpatientsdatafromtheobservationalstudyverve AT petrapichler pb1938realworldeffectivenessandsafetyofvenetoclaxincombinationwithobinutuzumabintreatmentnaivecllpatientsdatafromtheobservationalstudyverve |